Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Medicamen Biotech Ltd

MEDICAMEQ.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Micro Cap Analyst: N/A

Last Close

$2.52

▼ -0.24%

Market Cap $34.17M · Vol 12.90K

Key Metrics

P/E Ratio

30.96

FWD: N/A

Market Cap

$34.17M

Micro Cap

Div Yield

0.42%

Annual dividend

EPS Growth

N/A

YoY

RSI (14)

49.20

Momentum

Beta

1.15

vs Market

52W High

$4.69

49.84% below

52W Low

$2.23

12.14% above

Volume

12.90K

Avg 15.44K

P/B

1.10

Price-to-book

ROE

N/A

Return on equity

Free Float

37.03%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Medicamen Biotech Ltd (MEDICAMEQ.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does MEDICAMEQ.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

+2.02%

+3.15%

-11.53%

-31.94%

YTD

-34.06%

-31.88%

-73.09%

N/A

Financials & Valuation

TTM · Annual

Total Revenue	$21.16M
Net Income	$1.05M
Revenue Growth (YoY)	+11.27%
Gross Margin	44.89%
Operating Margin	6.25%
Net Profit Margin	4.95%
ROE	N/A
ROA · ROIC	3.58% · 4.38%

P/E Ratio	30.96
Forward P/E (FY1)	N/A
PEG Ratio	1.06
P/S	1.51
P/B	1.10
P/FCF	N/A
EPS Growth	N/A
Outstanding Shares	13.56M

Technical Indicators

50-Day SMA	$2.50
200-Day SMA	$3.20
RSI (14)	49.20
Beta	1.15
52-Week High	$4.69
52-Week Low	$2.23

Volume Today	12.90K
Avg Daily Volume (30D)	15.44K
Relative Volume	0.84x
Volatility (10D)	32.15
Volatility (30D)	32.47
Free Float	37.03%

Analyst Consensus

N/A

Current Price $2.52

Mean Target N/A

52W Low$2.23 52W High$4.69

Current

Target

$2.23 $4.69

Current Analyst target

· 0 analysts

Identifiers

ExchangeNSE India

FIGIBBG001S8LX58

ISININE646B01010

CountryIndia

Sub-IndustryGeneric Pharmaceuticals

Earnings DateN/A

TypeStocks

Instrument TypeFULLPAID Fully Paid Ordinary

Similar Halal Stocks

SUNPHARMA.NS Sun Pharmaceutical Industries Ltd -0.10% 4578.T Otsuka Holdings Co Ltd -3.26% CIPLA.NS Cipla Ltd -0.60% ZYDUSLIFE.NS Zydus Lifesciences Ltd -2.75% RICHTER.BU Richter Gedeon Vegyeszeti Gyar Nyrt +1.56%

Company Profile

Medicamen Biotech Limited is an India-based integrated pharmaceutical and life sciences solution provider. The Company is principally engaged in generic finished dosage forms (FDF), Oncology formulations and research and development services to cater to the needs of the global pharmaceutical industry. The Company’s focus areas include antibiotics, hypertension, general pain management, cardiovascular, diabetics and oncology formulations. In cardiology, the Company is delivering effective treatments for heart-related conditions. Its CNS products address neurological disorders, while its diabetology solutions focus on advanced diabetes management. It also contributes to the global fight against malaria with its anti-malarial medications. Additionally, the Company offers essential vitamins, antibiotics for bacterial infections, and comprehensive pain management solutions. Its oncology products include Abiraterone acetate, Anastrozole, Bicalutamide, Bendmustine HCL, and others.